New report blames administration mismanagement, Gilead monopoly for shortages of COVID-19 drug - CBS News
A new report says some hospitals around the country did not get enough of a critical drug used for COVID-19 patients. The FDA approved the drug, Remdesivir, for emergency use in May. But the report says after looking at the data, the Trump administration mismanaged its distribution. Anna Werner reports.
View CBS News In